These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 15157827)

  • 21. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
    Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
    J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
    Elson CO
    N Engl J Med; 2002 Feb; 346(8):614-6. PubMed ID: 11856802
    [No Abstract]   [Full Text] [Related]  

  • 25. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signalling pathways and molecular interactions of NOD1 and NOD2.
    Strober W; Murray PJ; Kitani A; Watanabe T
    Nat Rev Immunol; 2006 Jan; 6(1):9-20. PubMed ID: 16493424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOD2/CARD15: relevance in clinical practice.
    Vermeire S
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):569-75. PubMed ID: 15157828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of NOD2 gene in Crohn's disease].
    Hugot JP
    Gastroenterol Clin Biol; 2002 Jan; 26(1):13-5. PubMed ID: 11938034
    [No Abstract]   [Full Text] [Related]  

  • 32. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis.
    Stockton JC; Howson JM; Awomoyi AA; McAdam KP; Blackwell JM; Newport MJ
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):157-60. PubMed ID: 15145460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease.
    Ferreirós-Vidal I; Amarelo J; Barros F; Carracedo A; Gómez-Reino JJ; Gonzalez A
    J Rheumatol; 2003 Jan; 30(1):102-4. PubMed ID: 12508397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applications of advances in the genetics of IBD.
    Sartor RB
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S9-17. PubMed ID: 12684584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population.
    Nagy Z; Karádi O; Rumi G; Rumi G; Pár A; Mózsik G; Czirják L; Süto G
    Ann N Y Acad Sci; 2005 Jun; 1051():45-51. PubMed ID: 16126943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NOD2: A functional and positional candidate gene in Crohn's disease].
    Folwaczny C; Glas J
    Z Gastroenterol; 2002 Mar; 40(3):205-7. PubMed ID: 11901457
    [No Abstract]   [Full Text] [Related]  

  • 40. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
    Kobayashi KS; Chamaillard M; Ogura Y; Henegariu O; Inohara N; Nuñez G; Flavell RA
    Science; 2005 Feb; 307(5710):731-4. PubMed ID: 15692051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.